Vanguard Group’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.78B | Sell |
|
|||||
2025
Q1 | $1.39B | Buy |
|
|||||
2024
Q4 | $1.26B | Buy |
|
|||||
2024
Q3 | $1.25B | Buy |
|
|||||
2024
Q2 | $1.07B | Buy |
|
|||||
2024
Q1 | $394M | Buy |
|
|||||
2023
Q4 | $438M | Sell |
|
|||||
2023
Q3 | $362M | Buy |
|
|||||
2023
Q2 | $281M | Sell |
|
|||||
2023
Q1 | $228M | Buy |
|
|||||
2022
Q4 | $261M | Buy |
|
|||||
2022
Q3 | $245M | Buy |
|
|||||
2022
Q2 | $222M | Buy |
|
|||||
2022
Q1 | $261M | Sell |
|
|||||
2021
Q4 | $303M | Buy |
|
|||||
2021
Q3 | $298M | Buy |
|
|||||
2021
Q2 | $303M | Buy |
|
|||||
2021
Q1 | $330M | Buy |
|
|||||
2020
Q4 | $312M | Buy |
|
|||||
2020
Q3 | $295M | Sell |
|
|||||
2020
Q2 | $259M | Buy |
|
|||||
2020
Q1 | $135M | Buy |
|
|||||
2019
Q4 | $195M | Buy |
|
|||||
2019
Q3 | $144M | Buy |
|
|||||
2019
Q2 | $204M | Buy |
|
|||||
2019
Q1 | $206M | Buy |
|
|||||
2018
Q4 | $91.2M | Buy |
|
|||||
2018
Q3 | $138M | Buy |
|
|||||
2018
Q2 | $157M | Buy |
|
|||||
2018
Q1 | $145M | Buy |
|
|||||
2017
Q4 | $197M | Buy |
|
|||||
2017
Q3 | $146M | Buy |
|
|||||
2017
Q2 | $65.7M | Buy |
|
|||||
2017
Q1 | $66.2M | Buy |
|
|||||
2016
Q4 | $47.7M | Buy |
|
|||||
2016
Q3 | $50.6M | Buy |
|
|||||
2016
Q2 | $33.6M | Buy |
|
|||||
2016
Q1 | $41.2M | Buy |
|
|||||
2015
Q4 | $58.2M | Buy |
|
|||||
2015
Q3 | $54.8M | Buy |
|
|||||
2015
Q2 | $47.4M | Buy |
|
|||||
2015
Q1 | $32.6M | Buy |
|
|||||
2014
Q4 | $20.5M | Buy |
|
|||||
2014
Q3 | $15.5M | Buy |
|
|||||
2014
Q2 | $19.8M | Buy |
|
|||||
2014
Q1 | $17.9M | Buy |
|
|||||
2013
Q4 | $14.5M | Buy |
|
|||||
2013
Q3 | $12.2M | Buy |
|
|||||
2013
Q2 | $7.93M | Buy |
|